Arterial hypertension and COVID-19: the role of angiotensin-converting enzyme receptors in infection
https://doi.org/10.52485/19986173_2023_1_104
Abstract
The aim of this work was an attempt to systematize the data available in the available literature on the risk of developing coronavirus infection (COVID-19) in patients with arterial hypertension (AH), the role of angiotensin-converting enzyme receptors in infection.
Given the number of victims of the new coronavirus infection caused by the SARSCoV-2 virus (COVID-19), on March 11, 2020, the World Health Organization declared a pandemic since December 2019, when the first case of SARS was detected in China. A large amount of data has been accumulated on the close relationship between the severity of the course of COVID-19 disease and various comorbidities, in particular arterial hypertension (AH). Including more and more publications both about a significantly greater risk of infection with COVID-19 in people with diseases of the cardiovascular system (CVS), in particular, hypertension, coronary artery disease, and about the risk of complications in this group of patients. The article discusses the risks of severe COVID-19 disease in patients with hypertension, including the role of angiotensin-converting enzyme receptors.
Keywords
coronavirus,
COVID-19,
arterial hypertension,
renin-angiotensin-aldosterone system receptors,
angiotensinconverting enzym
Supporting agencies: The study had no financial support
About the Authors
E. P. Antipova
Omsk State Medical University
Russian Federation
Russian Federation
644099; 12 Lenina str.; Omsk
M. V. Moiseeva
Omsk State Medical University
Russian Federation
Russian Federation
644099; 12 Lenina str.; Omsk
N. V. Bagisheva
Omsk State Medical University
Russian Federation
Russian Federation
644099; 12 Lenina str.; Omsk
A. V. Mordyk
Omsk State Medical University; National Medical Research Center for Phthisiopulmonology and Infectious Diseases
Russian Federation
Russian Federation
644099; 12 Lenina str.; Omsk; 127473; 4 Dostoevskogo str., building 2; Moscow
E. G. Dzhusoeva
Omsk State Medical University
Russian Federation
Russian Federation
644099; 12 Lenina str.; Omsk
V. V. Streltsova
Omsk State Medical University
Russian Federation
Russian Federation
644099; 12 Lenina str.; Omsk
References
1. Rotar' O.P., Konradi A.O. Korostovtseva L.S. COVID‑19: What are the risks of patients with hypertension. Arterial'nayagipertenziya. 2020. 26(2). 124–132. DOI: 10.18705/1607-419X-2020-26-2-124-132. in Russian.
2. Zagidullin N.Sh., Gareeva D.F., Ishmetov V.Sh., Pavlov A.V., Plotnikova M.R., Pushkareva A.E., Pavlov V.N. Renin-angiotensin system in the new coronavirus infection COVID-2019. Arterial'naya gipertenziya. 2020. 26(3). 240–247. DOI: 10.18705/1607-419X-2020-26-3-240-247. in Russian.
3. Karnik S.S., Unal H., Kemp J.R. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic stimuli. Pharmacol Rev. 2015. 67(4). 754–819. DOI: 10.1124/pr.114.010454.
4. Donoghue M., Hsieh F., Baronas E. A. novel angiotensin-converting enzyme-relatedcarboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9. Circ Res. 2000. 87. E1–9. DOI: 10.1161/01.res.87.5.e1
5. Shirogane Y., Takeda M., Iwasaki M. Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2. J.Virol. 2008. 82(17). 8942–6. DOI: 10.1128/JVI.00676-08.
6. Chazova I.E., Blinova N.V., Nevzorova V.A. The consensus of experts of the Russian Medical Society on arterial hypertension: arterial hypertension and COVID-19. Sistemnye gipertenzii. 2020. 17(3). 35–41. DOI: 10.26442/2075082X.2020.3.200362. in Russian.
7. Donoghue M., Hsieh F., Baronas E. A novel angiotensin-converting enzyme-relatedcarboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9. Circ Res. 2000. 87. E1–9. DOI: 10.1161/01.res.87.5.e1.
8. Karpunina N.S., Khlynova O.V., Shumovich I.V. Heart disease in COVID-19: Immediate and remote observations. Permskiy meditsinskiy zhurnal. 2021. 38(3). 48-60. URL: https://cyberleninka.ru/article/n/porazhenie-serdtsa-pri-covid-19-neposredstvennye-i-otdalennye-nablyudeniya.. in Russian.
9. Inciardi R.M., Lupi L., Zaccone G. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMACardiol. 2020. 5. 819–824.
10. Guo T., Fan Y., Chen M. Cardiovascular implications of fatal outcomes of patients with 1. coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020. 5. 811–818.
11. Ma K.L., Liu Z.H., Cao C.F., Liu M.K., Liao J., Zou J.B., Wang H.Q. COVID-19 myocarditis and severity factors: an adult cohort study. MedRxiv. 2020. https://www.medrxiv.org/content/10.1101/2020.03.19.20034124v1.
12. Zabozlaev F.G., Kravchenko E.V., Gallyamova A.R., Letunovskiy N.N. Pathological anatomy of the lungs in a new coronavirus infection (COVID-19). Preliminary analysis of autopsy studies. Klinicheskaya praktika. 2020. 11(2). 21–37. DOI: 10.17816/clinpract34849. in Russian.
13. Tian X Li.C., Huang A. Potent binding of 2019 novelcoronavirus spike protein by a SARS coronavirus-specific humanmonoclonal antibody. Emerg Microbes Infect. 2020. 9(1). 382–385. DOI: 10.1080/22221751.2020.1729069.
14. Abaturov A.E., Agafonova E.A., Krivusha E.L., Nikulina A.A. Pathogenesis of COVID-19. Zdorov'e rebenka. 2020. 15(2). 133–144. DOI: 10.22141/2224-0551.15.2.2020.200598. in Russian.
15. Zaytsev A.A., Chernov S.A., Stets V.V. Algorithms for the management of patients with the new COVID-19 coronavirus infection in the hospital. Metodicheskiye rekomendatsii. Moscow: Main Military Clinical Hospital N.N. Burdenko. 2020. in Russian.
16. Turchina M.S., Mishina A.S., Veremeychik A.L., Reznikov R.G. Clinical features of gastrointestinal tract lesions in patients with new coronavirus infection COVID-19. Aktual'nye problemy meditsiny. 2020. 44(1). 5–15. URL: https://cyberleninka.ru/article/n/klinicheskie-osobennosti-porazheniya-zheludochno-kishechnogo-trakta-u-bolnyh-s-novoy-koronavirusnoy-infektsiey-covid-19.
17. Zhenyu F., Liping Ch., Jun L., Cheng T., Yajun Zh., Shaoping H., Zhanju L., Jilin Ch.. Clinical Features of COVID-19. Clinical Gastroenterology and Hepatology doi: 10.1016/j.cgh.2020.04.002 https://www.medrxiv.org/content/10.1101/2020.02.26.20026971v2.
18. Zhang H., Kang Z., Gong H., Xu D., Wang J., Li Z., Cui X. The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. BioRxiv, 2020.org2020. DOI: 10.1101/2020.01.30.927806.
19. Wang L., He W., Yu X., Hu D., Bao M., Liu H. Coronavirus Disease 2019 in elderly patients: characteristics and prognosticfactors based on 4-week follow-up. J Infection. 2020. DOI: 10.1016/j.jinf.2020.03.019 .
20. Kravchuk E.N., Neymark A.E., Babenko A.Yu., Grineva E.N. Obesity and COVID-19. Arterial'naya gipertenziya. 2020. 26(4). 439–445. DOI: 10.18705/1607-419X-2020-26-4-440-446. in Russian.
21. Peng Y.D., Meng K., Guan H.Q., Leng L., Zhu R.R., Wang B.Y. Clinical characteristics and outcomes of 112 cardiovasculardisease patients infected by 2019-nCoV. 2020. 48: E 004. DOI: 10.3760/cma.j.cn112148-20200220-00105.
22. Boykov V.A., Kobyakova O.S., Deyev I.A., Kulikov Y.S., Starovoytova Y.A.. State of respiratory function in patients with obesity. Bulletin of Siberian Medicine. 2013. 12(1). 86–92. DOI: 10.20538/1682-0363-2013-1-86-92. in Russian.
23. Ouchi N., Parker J.L, Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011. 11(2). 85–97. DOI: 10.1038/nri2921.
24. De Pergola G., Pannacciulli N. Coagulation and fibrinolysis abnormalities in obesity. J Endocrinol Invest. 2002. 25(10). 899–904. DOI: 10.1007/BF03344054.
25. Santilli F., Vazzana N., Liani R., Guagnano M.T., Davì.G. Platelet activation in obesity and metabolic syndrome. Obes Rev.2012. 13(1). 27–42. DOI: 10.1111/j.1467-789X.2011.00930.x
26. Zhang Y., Xiao M., Zhang S., Xia P., Cao W., Jiang W. Coagulopathy and antiphospholipid antibodies in patients with COVID‑19. N Engl J Med. 2020. 382(17). DOI: 10.1056/NEJMc2007575.
27. Blinova N.V., Zhernakova Yu.V., Azimova M.O., Andreevskaya M.V., Chazova I.E. Vliyanie sistemnykh i ektopicheskikh zhirovykh depo na sostoyanie funktsii pochek. Sistemnye gipertenzii. 2022;19(4):5-15. doi: 10.38109/2075-082X-2022-4-5-15. in Russian.
28. Agababyan I.R., Soleeva S.Sh. Ipertensione arteriosa e comorbilitàassociata. Problemy biologii i meditsiny. 2020. 6(124). 211-215. URL: https://cyberleninka.ru/article/n/arterialnaya-gipertoniya-i-komorbidnost.. in Russian.
29. Xiong T.Y, Redwood S., Prendergast B., Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. European Heart Journal. 2020. 41(19). 1798–800. DOI: 10.1093/eurheartj/ehaa231.
30. Madjid M., Safavi-Naeini P., Solomon S.D., Var-deny O. Potential Effects of Coronaviruses on the Cardiovascular System. JAMA Cardiolo-gy. 2020. DOI: 10.1001/jamacardio.2020.1286
31. Gorabi A.M, Kiaie N., Hajighasemi S, Banach M, Penson P.E., Jamialahmadi T. Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic Implications. Journal of Clinical Medicine. 2019. 8(12). 2051. DOI: 10.3390/jcm8122051
32. Arutyunov G.P., Tarlovskaya E.I., Kozlov N.A., Boldin M.V., Batyushin M.M., Ametov A.S. The agreed position of the experts of the Eurasian Association of Therapists on the tactics of management of patients with comorbid pathology infected with SARS-CoV-2. Terapevticheskiy arkhiv. 2020. 92(9). 108–124. DOI: 10.26442/00403660.2020.09.000703. in Russian.
33. Suliburska J., Bogdanski P., Szulinska M., Pupek-Musialik D. The influence of antihypertensive drugs on mineral status in hypertensive patients. European Review for Medical and Pharmacological Sciences. 2014.1 8(1). 58–65
34. Chiba M., Katayama K., Takeda R., Morita R., Iwahashi K., Onishi Y. Diuretics aggravate zinc deficiency in patients with liver cirrhosis by increasing zinc excretion in urine. Hepatol Res. 2013. 43(4). 365–73.
35. Wang L, He W, Yu X, Hu D, Bao M, Liu H et al. Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infection. 2020. doi: 10.1016/j.jinf.2020.03.019 [Epubahead of print].
Review
For citations:
Antipova E.P., Moiseeva M.V., Bagisheva N.V., Mordyk A.V., Dzhusoeva E.G., Streltsova V.V. Arterial hypertension and COVID-19: the role of angiotensin-converting enzyme receptors in infection. Transbaikalian Medical Bulletin. 2023;(1):104-112. (In Russ.) https://doi.org/10.52485/19986173_2023_1_104
Views:
116
Email this article 